Stammdaten
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
Unternehmen & Branche
| Name | BeyondSpring Inc. |
|---|---|
| Ticker | BYSI |
| CIK | 0001677940 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 64,1 Mio. USD |
| Beta | 0,51 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -1,006,000 | 25,933,000 | -32,161,000 | ||
| 2025-09-30 | 10-Q | -1,540,000 | -0.03 | 29,484,000 | -31,775,000 | |
| 2025-06-30 | 10-Q | -1,806,000 | -0.10 | 31,043,000 | -30,216,000 | |
| 2025-03-31 | 10-Q | 4,477,000 | 37,104,000 | -28,309,000 | ||
| 2024-12-31 | 10-K | -11,123,000 | 34,315,000 | -32,900,000 | ||
| 2024-09-30 | 10-Q | -2,132,000 | ||||
| 2024-06-30 | 10-Q | -4,031,000 | -0.04 | |||
| 2024-03-31 | 10-Q | -3,231,000 | ||||
| 2023-12-31 | 10-K | -21,026,000 | 24,808,000 | -26,805,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -45,513 | 1.76 | -80,102.88 | -249,8% | |
| 2025-10-16 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -85,798 | 1.72 | -147,572.56 | -460,3% | |
| 2025-10-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -17,960 | 1.65 | -29,634.00 | -92,4% | |
| 2025-10-14 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -28,495 | 1.65 | -47,016.75 | -146,6% | |
| 2025-10-13 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -107,361 | 1.70 | -182,513.70 | -569,2% | |
| 2025-10-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,390 | 1.77 | -4,230.30 | -13,2% | |
| 2025-10-09 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,979 | 1.81 | -7,201.99 | -22,5% | |
| 2025-10-08 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -7,507 | 1.77 | -13,287.39 | -41,4% | |
| 2025-10-07 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,100 | 1.79 | -3,759.00 | -11,7% | |
| 2025-10-06 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -17,500 | 1.78 | -31,150.00 | -97,2% | |
| 2025-10-03 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -600 | 1.76 | -1,056.00 | -3,3% | |
| 2025-10-02 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -600 | 1.73 | -1,038.00 | -3,2% | |
| 2025-10-01 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,601 | 1.80 | -4,681.80 | -14,6% | |
| 2025-09-30 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -4,464 | 1.81 | -8,079.84 | -25,2% | |
| 2025-09-29 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -500 | 1.75 | -875.00 | -2,7% | |
| 2025-09-26 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -600 | 1.68 | -1,008.00 | -3,1% | |
| 2025-09-25 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -700 | 1.66 | -1,162.00 | -3,6% | |
| 2025-09-24 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,256 | 1.68 | -3,790.08 | -11,8% | |
| 2025-09-23 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -4,106 | 1.72 | -7,062.32 | -22,0% | |
| 2025-09-22 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -5,410 | 1.83 | -9,900.30 | -30,9% | |
| 2025-09-19 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,656 | 1.79 | -6,544.24 | -20,4% | |
| 2025-09-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -5,307 | 1.74 | -9,234.18 | -28,8% | |
| 2025-09-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,304 | 1.83 | -4,216.32 | -13,2% | |
| 2025-09-16 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -840 | 1.88 | -1,579.20 | -4,9% | |
| 2025-09-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,570 | 1.84 | -4,728.80 | -14,7% | |
| 2025-09-12 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -700 | 1.85 | -1,295.00 | -4,0% | |
| 2025-09-11 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,820 | 1.90 | -7,258.00 | -22,6% | |
| 2025-09-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -8,176 | 1.93 | -15,779.68 | -49,2% | |
| 2025-09-09 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -9,050 | 1.97 | -17,828.50 | -55,6% | |
| 2025-09-08 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -7,090 | 1.93 | -13,683.70 | -42,7% | |
| 2025-09-05 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -1,106 | 1.86 | -2,057.16 | -6,4% | |
| 2025-09-04 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -803 | 1.82 | -1,461.46 | -4,6% | |
| 2025-09-03 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -1,270 | 1.81 | -2,298.70 | -7,2% | |
| 2025-09-02 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,800 | 1.78 | -4,984.00 | -15,5% | |
| 2025-08-29 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -800 | 1.74 | -1,392.00 | -4,3% | |
| 2025-08-28 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -809 | 1.81 | -1,464.29 | -4,6% | |
| 2025-08-27 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -1,300 | 1.78 | -2,314.00 | -7,2% | |
| 2025-08-26 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,000 | 1.79 | -3,580.00 | -11,2% | |
| 2025-08-25 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -300 | 1.77 | -531.00 | -1,7% | |
| 2025-08-22 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,376 | 1.75 | -4,158.00 | -13,0% | |
| 2025-08-21 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,034 | 1.79 | -5,430.86 | -16,9% | |
| 2025-08-20 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,456 | 1.74 | -6,013.44 | -18,8% | |
| 2025-08-19 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -3,604 | 1.77 | -6,379.08 | -19,9% | |
| 2025-08-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -47,668 | 2.03 | -96,766.04 | -301,8% | |
| 2025-08-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,900 | 2.00 | -5,800.00 | -18,1% | |
| 2025-08-14 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,000 | 2.00 | -4,000.00 | -12,5% | |
| 2025-08-04 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,196 | 2.18 | -4,787.28 | -14,9% | |
| 2025-07-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -900 | 2.20 | -1,980.00 | -6,2% | |
| 2025-07-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -20,572 | 2.19 | -45,052.68 | -140,5% | |
| 2025-07-16 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -5,396 | 2.24 | -12,087.04 | -37,7% | |
| 2025-07-15 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -2,152 | 2.28 | -4,906.56 | -15,3% | |
| 2025-07-14 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -801 | 2.29 | -1,834.29 | -5,7% | |
| 2025-07-11 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -246 | 2.29 | -563.34 | -1,8% | |
| 2025-07-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -768 | 2.28 | -1,751.04 | -5,5% | |
| 2025-07-09 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -252 | 2.27 | -572.04 | -1,8% | |
| 2025-07-08 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -9,059 | 2.29 | -20,745.11 | -64,7% | |
| 2025-07-02 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -324 | 2.42 | -784.08 | -2,4% | |
| 2025-07-01 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -600 | 2.43 | -1,458.00 | -4,5% | |
| 2025-06-23 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -1,700 | 3.09 | -5,253.00 | -16,4% | |
| 2025-06-20 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -225,217 | 3.16 | -711,685.72 | -2219,7% | |
| 2025-06-20 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -60,000 | 3.11 | -186,600.00 | -582,0% | |
| 2025-06-18 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -59,253 | 3.17 | -187,832.01 | -585,8% | |
| 2025-06-17 | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% Owner | Open Market Sale | -5,000 | 3.23 | -16,150.00 | -50,4% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.